12:00 AM
 | 
Nov 23, 2009
 |  BC Week In Review  |  Clinical News  |  Clinical Results

Vytorin ezetimibe/simvastatin: Post-marketing study data

A retrospective analysis of pharmacy and medical claims data from 29,949 patients showed that there was no significant difference in cardiovascular outcomes for patients treated with cholesterol drugs Vytorin ezetimibe/simvastatin, Lipitor...

Read the full 144 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >